Skip to main content
OpenTrials
Completed

NCT Number: NCT00043693

Family Intervention for Mental Illness and Substance Abuse

This study will evaluate a family intervention program for individuals with bipolar disorder, schizophrenia, or schizoaffective disorder and co-occurring substance use disorders.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Pacific Clinics El Camino, Santa Fe Springs, California, United States

Loading trial locations.

About this study

Substance use disorder (SUD) in persons with severe mental illness may worsen the course of psychiatric illness. The loss of family support for individuals with mental illness is a major contributing factor to housing instability, homelessness, and other problems. Despite progress toward integrating mental health and substance abuse services, interventions that improve the course of mental illness while helping the families of the mentally ill are not currently available. Enhancing skills for coping with mental illness may be an effective strategy for treating SUD, decreasing caregiver burden, and improving the long-term outcomes for people with mental illness.

Patients and their families are randomly assigned to either the Family Intervention for Dual Diagnosis (FIDD) program or family psychoeducation. The FIDD program lasts for up to 3 years and includes both single and multiple-family group formats. The family psychoeducation program consists of 6 weekly sessions. Routine assessments are conducted on all patients, and relatives are evaluated on a wide range of outcomes, including substance abuse, hospitalizations, psychiatric symptoms, legal problems, aggression, housing and homelessness, family burden, social support, and quality of life. To determine the effectiveness of the FIDD program, knowledge of mental illness and problem-solving skills are assessed in the families following treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Have schizophrenia, schizoaffective disorder, or bipolar disorder
  • Have a current substance use disorder (within the past 6 months)
  • Are willing to have at least 4 hours of contact per week with family members or significant others
  • Plan to remain in the community
  • Have family members or significant others who consent to participate in the study and plan to remain in the community

Treatment and study plan

Family Intervention for Dual Diagnosis

Behavioral

The family intervention for dual diagnosis program lasts for up to 3 years and includes both single and multiple-family group formats.

Family psychoeducation program

Behavioral

The family psychoeducation program consists of 6 weekly sessions.

Primary outcomes

  1. Alcohol use scale-revised

    Time frame: Measured at baseline, during treatment, and post-treatment

  2. Drug use scale-revised

    Time frame: Measured at baseline, during treatment, and post-treatment

  3. Substance abuse treatment scale

    Time frame: Measured at baseline, during treatment, and post-treatment

  4. Timeline followback calandar

    Time frame: Measured at baseline, during treatment, and post-treatment

Sponsors and collaborators

Lead sponsor

Dartmouth-Hitchcock Medical Center

Other

Collaborators

  • National Institute of Mental Health (NIMH)

Registry information

Official study title

Family Intervention for SMI and Substance Use Disorder

Important dates

Study start
2002
Primary completion
2008
Study completion
2008
First posted
Aug 15, 2002
Registry last updated
Aug 8, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.